KR20110091534A - 모르핀-6-글루쿠로니드 또는 그의 유도체 중 하나의 합성 - Google Patents

모르핀-6-글루쿠로니드 또는 그의 유도체 중 하나의 합성 Download PDF

Info

Publication number
KR20110091534A
KR20110091534A KR1020117013141A KR20117013141A KR20110091534A KR 20110091534 A KR20110091534 A KR 20110091534A KR 1020117013141 A KR1020117013141 A KR 1020117013141A KR 20117013141 A KR20117013141 A KR 20117013141A KR 20110091534 A KR20110091534 A KR 20110091534A
Authority
KR
South Korea
Prior art keywords
diyl
group
formula
dimorphin
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
KR1020117013141A
Other languages
English (en)
Korean (ko)
Inventor
알렝 들루발라
이자벨르 리포쉐
클레르 트레캉
Original Assignee
사노피
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 사노피 filed Critical 사노피
Publication of KR20110091534A publication Critical patent/KR20110091534A/ko
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
KR1020117013141A 2008-12-10 2009-12-08 모르핀-6-글루쿠로니드 또는 그의 유도체 중 하나의 합성 Abandoned KR20110091534A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0806948 2008-12-10
FR0806948A FR2939436B1 (fr) 2008-12-10 2008-12-10 Synthese de morphine-6-glucuronide ou de l'un de ses derives

Publications (1)

Publication Number Publication Date
KR20110091534A true KR20110091534A (ko) 2011-08-11

Family

ID=40996840

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020117013141A Abandoned KR20110091534A (ko) 2008-12-10 2009-12-08 모르핀-6-글루쿠로니드 또는 그의 유도체 중 하나의 합성

Country Status (30)

Country Link
US (1) US8258298B2 (https=)
EP (1) EP2376496B1 (https=)
JP (1) JP5619768B2 (https=)
KR (1) KR20110091534A (https=)
CN (1) CN102307876B (https=)
AR (1) AR074513A1 (https=)
AU (1) AU2009326906B2 (https=)
BR (1) BRPI0923238A2 (https=)
CA (1) CA2746428A1 (https=)
CL (1) CL2011001398A1 (https=)
CO (1) CO6390060A2 (https=)
CR (1) CR20110307A (https=)
EA (1) EA201170790A1 (https=)
EC (1) ECSP11011100A (https=)
ES (1) ES2470666T3 (https=)
FR (1) FR2939436B1 (https=)
HN (1) HN2011001597A (https=)
IL (1) IL213379A0 (https=)
MA (1) MA32950B1 (https=)
MX (1) MX337925B (https=)
MY (1) MY152276A (https=)
NI (1) NI201100116A (https=)
NZ (1) NZ593342A (https=)
PE (1) PE20110836A1 (https=)
SG (1) SG172069A1 (https=)
TN (1) TN2011000243A1 (https=)
TW (1) TW201033218A (https=)
UA (1) UA103643C2 (https=)
WO (1) WO2010067007A2 (https=)
ZA (1) ZA201104657B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10807995B2 (en) 2018-07-13 2020-10-20 Alkermes Pharma Ireland Limited Thienothiophene compounds for long-acting injectable compositions and related methods
US10799496B2 (en) 2018-07-13 2020-10-13 Alkermes Pharma Ireland Limited Naphthylenyl compounds for long-acting injectable compositions and related methods
US10975099B2 (en) 2018-11-05 2021-04-13 Alkermes Pharma Ireland Limited Thiophene compounds for long-acting injectable compositions and related methods

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3766188A (en) * 1971-06-28 1973-10-16 Yamanouchi Pharma Co Ltd Carbonyldioxymorphinan derivatives
GB9116909D0 (en) * 1991-08-06 1991-09-18 Salford Ultrafine Chem & Res Morphine derivatives
GB2282758A (en) 1993-08-23 1995-04-19 Euro Celtique Sa Oral morphine-6-glucuronide compositions
DE69815336T2 (de) 1997-04-14 2004-05-06 Ufc Ltd. Morphin-derivate
PL194362B1 (pl) * 1998-06-06 2007-05-31 Cenes Ltd Sposób syntezy beta-anomeru morfino-6-glukuronidui zastosowanie związków
GB9914382D0 (en) * 1999-06-21 1999-08-18 Ufc Limited New process for the manufacture of morphine-6-glucuronide and its analogues and also to a manufacture of new intermediaries
KR20040014544A (ko) * 2001-06-05 2004-02-14 컨트롤 딜리버리 시스템즈 인코포레이티드 서방 진통제 화합물
US6740641B2 (en) * 2001-07-27 2004-05-25 Euro-Celtique, S.A. Sugar derivatives of hydromorphone, dihydromorphine and dihydromorphine, compositions thereof and uses for treating or preventing pain
KR20050008658A (ko) * 2002-03-19 2005-01-21 마이클 홀릭 아포모르핀의 글리코시드 및 오르토에스테르 글리코시드유도체들, 유사체들 및 그것의 용도
FR2864082B1 (fr) 2003-12-22 2006-03-10 Synt Em Nouveau derive de la morphine-6-glucuronide, composition pharmaceutique le contenant et son utilisation pour le traitement de la douleur

Also Published As

Publication number Publication date
SG172069A1 (en) 2011-07-28
ECSP11011100A (es) 2011-07-29
WO2010067007A3 (fr) 2011-07-07
HN2011001597A (es) 2013-09-09
ES2470666T3 (es) 2014-06-24
CO6390060A2 (es) 2012-02-29
MY152276A (en) 2014-09-15
UA103643C2 (ru) 2013-11-11
PE20110836A1 (es) 2011-11-25
TW201033218A (en) 2010-09-16
CN102307876B (zh) 2014-12-10
FR2939436A1 (fr) 2010-06-11
JP5619768B2 (ja) 2014-11-05
EA201170790A1 (ru) 2011-12-30
NZ593342A (en) 2013-07-26
CR20110307A (es) 2011-09-21
EP2376496A2 (fr) 2011-10-19
AR074513A1 (es) 2011-01-19
AU2009326906A1 (en) 2011-06-30
FR2939436B1 (fr) 2010-12-17
AU2009326906B2 (en) 2016-05-26
CA2746428A1 (fr) 2010-06-17
TN2011000243A1 (fr) 2012-12-17
CN102307876A (zh) 2012-01-04
JP2012511551A (ja) 2012-05-24
ZA201104657B (en) 2012-09-26
HK1163096A1 (en) 2012-09-07
WO2010067007A2 (fr) 2010-06-17
BRPI0923238A2 (pt) 2016-01-26
US20110275820A1 (en) 2011-11-10
CL2011001398A1 (es) 2011-10-28
MA32950B1 (fr) 2012-01-02
IL213379A0 (en) 2011-07-31
EP2376496B1 (fr) 2014-03-12
MX2011006264A (es) 2011-11-04
NI201100116A (es) 2011-12-14
MX337925B (es) 2016-03-28
US8258298B2 (en) 2012-09-04

Similar Documents

Publication Publication Date Title
CN112047888B (zh) 一种合成恩杂鲁胺的方法
KR20110091534A (ko) 모르핀-6-글루쿠로니드 또는 그의 유도체 중 하나의 합성
US4966996A (en) Process for the preparation of E-2-propyl-2-pentenoic acid and physiologically compatible salts thereof
KR100495107B1 (ko) 3-(파라-클로로페닐)-글루타르아미드의광학적분리방법
EP1791539A1 (en) Process to prepare camptothecin derivatives
US6602899B1 (en) β-D-5 thioxylose derivatives, preparation method and therapeutic use
JP2000503666A (ja) Mappia foetidaから単離したカンプトセシン―骨格化合物および新規な医薬ならびに治療薬のためのシントンとしてのその使用
HK1163096B (en) Synthesis of morphine-6-glucuronide or of a derivative thereof
US6489492B2 (en) Chiral derivatives of Garcinia acid bearing lactone ring moiety and process for preparing the same
JP4397990B2 (ja) 3−アルキルフラバノノール誘導体の精製法
CN1035005C (zh) 制备6-(3-二甲氨基丙酰基)福司可林的新方法
JP2917495B2 (ja) 光学活性1,2―プロパンジアミンの製造法
JP2917497B2 (ja) 光学活性1,2―プロパンジアミンの製造方法
JP3076883B2 (ja) 新規なテトラフェニルポルフィン配糖体
JP2917464B2 (ja) 光学活性1―メチル―3―フェニルプロピルアミンの製法
KR940009783B1 (ko) 항-기관지경련성 활성이 있는 n-알킬-노르트로핀의 에스테르와 그의 제 4 급유도체의 제조방법
JP2712669B2 (ja) 光学活性1,2―プロパンジアミンの製法
JP5247699B2 (ja) キラルピペリジンアルコールの分割プロセスおよびピペリジンアルコールを用いるピラゾロ−[1,5]−ピリミジン誘導体の合成プロセス
KR840000912B1 (ko) 2, 4-디아미노-5-설파모일 벤젠 설폰산의 제조방법
EP0101633A1 (en) Pyridinecarboxylic esters of dopamine and of its N-alkyl derivatives
JP2663295B2 (ja) ヘキサジエン酸誘導体及びその製法
KR810000483B1 (ko) N-알킬피페리딘 유도체의 제조 방법
JPH0510336B2 (https=)
KR960004449B1 (ko) 결정성 trh·타르트레이트의 제조방법
WO2004039772A1 (en) Process for preparing s-(2-aminoethyl)-2-methyl-l-cysteine

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20110609

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20141008

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20151215

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20160527

NORF Unpaid initial registration fee
PC1904 Unpaid initial registration fee